| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |